SMTL ID : 4qm0.2 (2 other biounits)

Crystal structure of RORc in complex with a tertiary sulfonamide inverse agonist

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x 39K: N-(2-methylpropyl)-N-({5-[4-(methylsulfonyl)phenyl]thiophen-2-yl}methyl)-1-phenylmethanesulfonamide(Non-covalent)

39K.1: 19 residues within 4Å: Chain A: Q.27, L.28, W.58, C.61, H.64, A.68, R.105, M.106, R.108, A.109, F.119, F.129, L.132, L.137, I.138, I.141, F.142, H.220 Ligands: DMS.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.58, A:W.58, A:H.64, A:A.68, A:A.109, A:L.132, A:L.137, A:I.138, A:I.141, A:F.142

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 5 residues within 4Å: Chain A: H.64, F.118, F.119, E.120 Ligands: 39K.1 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.120 Water bridges: A:G.121 pi-Cation interactions: A:H.64

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fauber, B.P. et al., Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists. Bioorg.Med.Chem.Lett. (2014)

Release Date

2014-09-17

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence